New coronavirus treatment drug Monoprevir capsules completed the first batch of import customs clearance in Shanghai

Read Time:2 Minute, 12 Second

On January 13, 2023, Interface News learned that Sinopharm Holding Co., Ltd. held the first China launch ceremony of the new coronavirus treatment drug Monoravir capsules in the distribution center within Shanghai Waigaoqiao Free Trade Zone. The first batch of the drug, totaling 18 consignments and 15.5 tons, was inspected and released by Shanghai Waigaoqiao Free Trade Zone Customs, and left the zone in the afternoon of the same day after completing import customs clearance procedures for timely release to the domestic market.

On December 29, 2022, the State Drug Administration, in accordance with the relevant provisions of the Drug Administration Law, conducted an emergency review and approval in accordance with the special drug approval procedures, and conditionally approved the import registration of Merzadone’s new coronavirus treatment drug, Monoprevir capsules.

At the beginning of January this year, this batch of monoprevir capsules entered the Waigaoqiao Free Trade Zone after entering through Pudong International Airport. Shanghai Pudong Airport Customs understood the customs clearance requirements of enterprises in advance, “one enterprise, one policy” to develop a customs clearance supervision program at the airport port, coordinate ground agents and other relevant units, to facilitate the timely entry of drugs into the free trade zone.

The Customs of Waigaoqiao Free Trade Zone follows the whole process of importing the goods and makes a plan for customs clearance in advance, and provides “7×24” online consultation service and “green channel” at the border. It took only 5 hours and 22 minutes for the relevant drug to enter the warehouse in the Free Trade Zone from the acceptance of declaration.

The first batch of import clearance of the new coronavirus treatment drug Monoprevir capsules in Shanghai Waigaoqiao Free Trade Zone.
Wai Gao Qiao Free Trade Zone Customs Deputy Director Dai Qian said that the Customs has given full play to the professionalism and convenience of logistics distribution in the Free Trade Zone, providing enterprises with a series of safe and convenient customs clearance measures such as “advance declaration” and “two-step declaration”, and establishing a drug customs clearance guarantee with pharmaceutical enterprises. We have set up a special team to respond to the demands of enterprises in the first time to ensure “zero delay” in drug import customs clearance and contribute to “health protection and serious illness prevention”.

According to the information of Sinopharm Holdings, after the first batch of monoprevir capsules go through the import process smoothly, the enterprise will also carry out the import of this kind of new coronavirus treatment drugs in batches according to the market demand in the future, and do its best to guarantee the supply of medical materials.